What is Rdx Bioscience?
RDx Bioscience operates as an advanced CAP accredited and CLIA certified clinical diagnostic laboratory. The company specializes in providing comprehensive diagnostic testing, supporting risk-bearing entities by applying laboratory tools and programs to achieve their quality goals. Their service model is designed around client needs, focusing on personalized care and exceeding industry standards. RDx Bioscience is committed to continuous innovation, aiming to provide access to the latest specialized clinical tests for patients and healthcare providers. The company's strategy aligns with the evolving healthcare landscape, emphasizing value-based care and the prevention of costly chronic conditions. By leveraging expertise in risk-based contracting and new diagnostic tools, RDx Bioscience offers proprietary algorithms to assist delegated medical groups, ACOs, Medicare STARs, MIPS, and state-based Medicaid incentive bonuses, thereby supporting health organizations in gaining a competitive advantage and improving care coordination.
How much funding has Rdx Bioscience raised?
Rdx Bioscience has raised a total of $1.8M across 2 funding rounds:
Debt
$1M
Debt
$750K
Debt (2020): $1M with participation from PPP
Debt (2021): $750K led by PPP
Key Investors in Rdx Bioscience
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for Rdx Bioscience?
The recent major strategic investment in RDx Bioscience signals a strong confidence in its business model and its capacity to navigate the complexities of value-based healthcare. With a focus on reducing hospital readmissions, optimizing future utilization, and enhancing care coordination through proprietary medication adherence assays and genetic testing, the company is well-positioned to capitalize on the growing demand for outcome-driven healthcare solutions. This capital infusion is expected to fuel further development of their diagnostic platforms and expand their reach to more risk-bearing entities, solidifying their role as a key partner in achieving quality healthcare goals.
See full Rdx Bioscience company page
